THALASSA BIO Trademark

Serial Number: 99281882

THALASSA BIO is a trademark filed by FL2024-004, Inc. on July 15, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Owner Contact Info

FL2024-004, Inc.

601 California Street, Suite 600
San Francisco, CA 94108

Entity Type: 03

Legal Representation

Attorney of Record

Trevor A. Caudle, Esq.

5,805 trademarks filed View all →

Correspondence Address

Trevor A. Caudle, Esq. Trevor Caudle Law Practice, PC

350 Bay Street, #100-363

San Francisco, CA 94133

United States

Trademark Details

Filing Date

July 15, 2025

Registration Date

Not Registered

Published for Opposition

December 30, 2025

Goods & Services

Pharmaceutical preparations for the treatment of muscle diseases and disorders, cardiac diseases and disorders, hematologic diseases and disorders, metabolic diseases and disorders, and central nervous system diseases and disorders; Biological preparations for the treatment of muscle diseases and disorders, cardiac diseases and disorders, hematologic diseases and disorders, metabolic diseases and disorders, and central nervous system diseases and disorders

Research and development services in the field of pharmaceutical preparations; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services of new pharmaceutical products; Research and development in the field of pharmaceutical preparations for treating muscle diseases and disorders, cardiac diseases and disorders, hematologic diseases and disorders, metabolic diseases and disorders, and central nervous system diseases and disorders; Laboratory services for the production of pharmaceuticals in the nature of treatment for muscle diseases and disorders, cardiac diseases and disorders, hematologic diseases and disorders, metabolic diseases and disorders and central nervous system diseases and disorders

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 24, 2026 NOAM

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jan 20, 2026 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Jan 20, 2026 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Jan 20, 2026 REAP

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 30, 2025 NPUB

PUBLISHED FOR OPPOSITION

Dec 30, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 24, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 4, 2025 CNSA

EXAMINER'S AMENDMENT ENTERED

Dec 4, 2025 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Dec 4, 2025 GNEN

EXAMINERS AMENDMENT E-MAILED

Dec 4, 2025 GNEA

EXAMINERS AMENDMENT -WRITTEN

Dec 4, 2025 CNEA

ASSIGNED TO EXAMINER

Dec 3, 2025 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 18, 2025 NWOS

APPLICATION FILING RECEIPT MAILED

Jul 15, 2025 MAFR

NEW APPLICATION ENTERED

Jul 15, 2025 NWAP

Related Trademarks

More in Same Class